Welcome to the monthly update from the Life Sciences team at S&B containing news about recent and topical developments.
Life Sciences Update - October 2018
A ‘carve out’ of the patented indications from the Summary of Product Characteristics (SmPC) for a generic product has the effect of limiting its marketing authorisation. In such circumstances the authority should not publish the full label on... Read more
The Court of Justice of the European Union (CJEU) has held that supplementary protection certificates (SPCs) are only available for medicinal products and not for medical devices incorporating medicinal products. SPCs extend patent protection for authorised... Read more
The Court of Justice of the European Union (CJEU) has held that the de-branding of products, without consent and for the purpose of importing or trading those products in the European Economic Area (EEA), is an infringement of the trade mark owner’s... Read more
Canary Wharf T1 Limited and the European Medicines Agency (EMA) are currently involved in litigation surrounding the EMA’s lease of office premises and the impending relocation by the EMA to Amsterdam. The EMA case highlights the issues arising... Read more
Stockpiling for Brexit
An article by Gustaf Duhs and Paula Harris covering recent government guidance on Brexit deal / no deal scenarios and offering practical tips has been published in PHARMAnetwork Magazine. Read more